Related Experiment Video
Updated: May 10, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Genetics of circulating proteins in newborn babies at high risk of type 1 diabetes
Mauro Tutino1, Nancy Yiu-Lin Yu1, Konstantinos Hatzikotoulas1
1Institute of Translational Genomics, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Insights
This study maps proteins in newborns genetically at risk for Type 1 diabetes, identifying five key proteins linked to disease development. These findings offer potential new drug targets for early intervention in this chronic autoimmune condition.
Area of Science:
- Genetics
- Immunology
- Metabolomics
Background:
- Type 1 diabetes is an autoimmune disease targeting pancreatic beta cells.
- Early detection and intervention are crucial for managing Type 1 diabetes.
- Circulating proteins can indicate early disease mechanisms.
Purpose of the Study:
- To create a genome-wide protein quantitative trait loci (pQTL) map in newborns at genetic risk for Type 1 diabetes.
- To identify proteins colocalizing with Type 1 diabetes GWAS signals.
- To explore the causal role of identified proteins in Type 1 diabetes etiology.
Main Methods:
- Genome-wide pQTL mapping in 695 newborns.
- Analysis of 1985 circulating proteins.
- Colocalization analysis and Mendelian randomization.
Main Results:
- Identified 535 pQTLs, including 62 specific to newborns.
- Showed colocalization of pQTLs for five proteins (CTRB1, APOBR, IL7R, CPA1, PNLIPRP1) with Type 1 diabetes GWAS signals.
- Causally implicated these five proteins in Type 1 diabetes development.
Conclusions:
- Newborn molecular profiles are valuable for discovering drug targets for childhood diseases.
- Identified proteins represent potential therapeutic targets for Type 1 diabetes.
- This research provides insights into the early molecular underpinnings of Type 1 diabetes.
Abstract:
Type 1 diabetes is a chronic, autoimmune disease characterized by the destruction of insulin-producing β-cells in the pancreas. Early detection can facilitate timely intervention, potentially delaying or preventing disease onset. Circulating proteins reflect dysregulated biological processes and offer insights into early disease mechanisms. Here, we construct a genome-wide pQTL map of 1985 proteins in 695 newborn babies (median age 2 days) at increased genetic risk of developing Type 1 diabetes. We identify 535 pQTLs (352 cis-pQTLs, 183 trans-pQTLs), 62 of which characteristic of newborns. We show colocalization of pQTLs for CTRB1, APOBR, IL7R, CPA1, and PNLIPRP1 with Type 1 diabetes GWAS signals, and Mendelian randomization causally implicates each of these five proteins in the aetiology of Type 1 diabetes. Our study illustrates the utility of newborn molecular profiles for discovering potential drug targets for childhood diseases of significant concern.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Rh Blood Group
Insulin Secretory Vesicles
Blood Types
ABO blood group
ABO antigens are glycoproteins encoded by genes present on...

